You just read:

Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection

News provided by

Eiger BioPharmaceuticals, Inc.

Jul 31, 2018, 08:00 ET